<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-viruses-12-00838">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Goethals</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Clayton</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>van Ginderen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vereycken</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Wagemans</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Geluykens</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Dockx</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Strijbos</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Smits</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Vos</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors</article-title>
  <source>J. Virol.</source>
  <year>2008</year>
  <volume>82</volume>
  <fpage>10366</fpage>
  <lpage>10374</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00470-08</pub-id>
  <?supplied-pmid 18715920?>
  <pub-id pub-id-type="pmid">18715920</pub-id>
 </element-citation>
</ref>
